Home
BMY
BMY News

Latest Bristol-Myers Squibb Company (BMY) News on October 30, 2025

ACCESS Newswire

a day ago

Global Initiative To Demonstrate Operational Excellence in Nigeria for Metastatic Colorectal Cancer Patients

Bristol-Myers Squibb (BMY) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

2 days ago

Bristol-Myers Squibb (BMY) To Report Earnings Tomorrow: Here Is What To Expect

5 High-Yield Stocks to Anchor Your Portfolio for Half a Decade

24/7 Wall St.

2 days ago

5 High-Yield Stocks to Anchor Your Portfolio for Half a Decade

Uh Oh !! Cathie Wood Predicts “Reality Check” (Sell-off) – 5 High-Yield Dividend Safety Stocks

24/7 Wall St.

2 days ago

Uh Oh !! Cathie Wood Predicts “Reality Check” (Sell-off) – 5 High-Yield Dividend Safety Stocks

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

GlobeNewswire

2 days ago

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

A Fresh Look at Bristol-Myers Squibb's Valuation After New Pipeline Progress and Phase 3 Sotyktu Results

Simply Wall St.

2 days ago

A Fresh Look at Bristol-Myers Squibb's Valuation After New Pipeline Progress and Phase 3 Sotyktu Results

Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight

PR Newswire

3 days ago

Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight

3 Dividend-Paying Drug Stocks to Buy at a Discount

Motley Fool

3 days ago

3 Dividend-Paying Drug Stocks to Buy at a Discount

What's in Store for These 5 Pharma Bigwigs This Earnings Season?

Zacks

3 days ago

What's in Store for These 5 Pharma Bigwigs This Earnings Season?

MT Newswires

3 days ago

Bristol-Myers Squibb Says New Data Show Efficacy of Sotyktu in Psoriatic Arthritis, Lupus

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 days ago

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?

Zacks

3 days ago

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?

Ahead of Bristol Myers (BMY) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

3 days ago

Ahead of Bristol Myers (BMY) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus

Business Wire

3 days ago

Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus

Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025

Business Wire

5 days ago

Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025

PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now?

Zacks

6 days ago

PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now?

Does Bristol-Myers Squibb’s 22% Drop in 2024 Suggest an Opportunity for Investors?

Simply Wall St.

7 days ago

Does Bristol-Myers Squibb’s 22% Drop in 2024 Suggest an Opportunity for Investors?

Analyst Says Bristol-Myers Squibb (BMY) Among the Best ‘Deep Value’ Stocks to Buy

Insider Monkey

7 days ago

Analyst Says Bristol-Myers Squibb (BMY) Among the Best ‘Deep Value’ Stocks to Buy

Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033 | Astute Analytica

GlobeNewswire

7 days ago

Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033 | Astute Analytica

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for

Zacks

7 days ago

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

7 days ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks

Motley Fool

8 days ago

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks

Bristol Myers Squibb (BMY) Stock Moves 2.18%: What You Should Know

Zacks

9 days ago

Bristol Myers Squibb (BMY) Stock Moves 2.18%: What You Should Know

Rates Going Lower Next Week: Our Top 5% Dividend Picks Could Soar

24/7 Wall St.

9 days ago

Rates Going Lower Next Week: Our Top 5% Dividend Picks Could Soar

Will BMY's Growth Portfolio Drive Third-Quarter Results?

Zacks

9 days ago

Will BMY's Growth Portfolio Drive Third-Quarter Results?

Pfizer's Q3 Non-Oncology Performance: Here's What to Expect

Zacks

10 days ago

Pfizer's Q3 Non-Oncology Performance: Here's What to Expect

2 High-Yield Dividend Stocks Too Cheap to Ignore

Motley Fool

11 days ago

2 High-Yield Dividend Stocks Too Cheap to Ignore

3 S&P 500 Stocks We Find Risky

StockStory

13 days ago

3 S&P 500 Stocks We Find Risky

MT Newswires

13 days ago

Bristol-Myers Squibb, SystImmune Report 'Promising' Results for Cancer Drug in Phase 1 Study

SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025

PR Newswire

13 days ago

SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025

ACCESS Newswire

13 days ago

In the Wake of Bristol Myers' $1.5B Business Acquisition, LegalMatch.com Emphasizes the Need for Expert Legal Guidance in Mergers

Bristol Myers Squibb Foundation Awards Grant to PATH to Improve Care for Inherited Blood Disorders in India

ACCESS Newswire

13 days ago

Bristol Myers Squibb Foundation Awards Grant to PATH to Improve Care for Inherited Blood Disorders in India

Does BMY's AI Collaboration With insitro Signal a New Growth Path in Neuroscience?

Simply Wall St.

14 days ago

Does BMY's AI Collaboration With insitro Signal a New Growth Path in Neuroscience?

ACCESS Newswire

14 days ago

HopeHealth Launches Phase 3 Clinical Trial Site To Advance Lupus Research With Support From Bristol Myers Squibb

NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?

Zacks

14 days ago

NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?

insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration

Insider Monkey

14 days ago

insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration

Deck Bio and ReTrax Therapeutics Awarded 2025 Bristol Myers Squibb Golden Tickets

PR Newswire

15 days ago

Deck Bio and ReTrax Therapeutics Awarded 2025 Bristol Myers Squibb Golden Tickets

ACCESS Newswire

15 days ago

Bristol Myers Squibb Foundation Announces $1 Million Donation to Patient Advocate Foundation

Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal

Insider Monkey

15 days ago

Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Orbital Therapeutics Deal

MT Newswires

16 days ago

Bristol Myers Squibb, insitro Extend Collaboration

insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform

Business Wire

16 days ago

insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform

Josh Brown Pitches Best AI Stock ‘Not a Lot of People Know About’

Insider Monkey

16 days ago

Josh Brown Pitches Best AI Stock ‘Not a Lot of People Know About’

BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?

Zacks

16 days ago

BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?

Every Word Matters: The Next Chapter of Our Universal Patient Language

ACCESS Newswire

16 days ago

Every Word Matters: The Next Chapter of Our Universal Patient Language

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types

Business Wire

17 days ago

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types

MT Newswires

17 days ago

Bristol-Myers Squibb Pays SystImmune $250 Million After First Patient Treated With Potential Breast Cancer Therapy

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

PR Newswire

17 days ago

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

Bristol-Myers Squibb (BMY): Assessing Valuation as Shares Slide Nearly 5% Over the Past Month

Simply Wall St.

18 days ago

Bristol-Myers Squibb (BMY): Assessing Valuation as Shares Slide Nearly 5% Over the Past Month

Bristol Myers Squibb’s Alzheimer’s Drug, BMS-986446, Granted FDA Fast Track Status

Insider Monkey

19 days ago

Bristol Myers Squibb’s Alzheimer’s Drug, BMS-986446, Granted FDA Fast Track Status

Equities Slide After Trump's China Tariffs Threat; Nasdaq Posts Worst Day Since April

MT Newswires

20 days ago

Equities Slide After Trump's China Tariffs Threat; Nasdaq Posts Worst Day Since April

MT Newswires

20 days ago

Sector Update: Health Care Stocks Decline Late Afternoon

Equities, Oil Slump Intraday After Trump's China Tariffs Threat

MT Newswires

20 days ago

Equities, Oil Slump Intraday After Trump's China Tariffs Threat

MT Newswires

20 days ago

Sector Update: Health Care Stocks Decline Friday Afternoon

BMS expands CAR-T portfolio with $1.5bn Orbital buyout

Pharmaceutical Technology

20 days ago

BMS expands CAR-T portfolio with $1.5bn Orbital buyout

MT Newswires

20 days ago

Sector Update: Health Care

Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.

Barrons.com

20 days ago

Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going.

Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal

MT Newswires

20 days ago

Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal

MT Newswires

20 days ago

Bristol-Myers Squibb to Acquire Orbital Therapeutics for $1.5 Billion

ACCESS Newswire

20 days ago

Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics

Business Wire

20 days ago

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection

Business Wire

20 days ago

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection

3 Value Stocks with Warning Signs

StockStory

21 days ago

3 Value Stocks with Warning Signs

What Do Recent Medicare Negotiation Plans Mean for Bristol-Myers Squibb Shares in 2025?

Simply Wall St.

21 days ago

What Do Recent Medicare Negotiation Plans Mean for Bristol-Myers Squibb Shares in 2025?

Can BMYs Neuroscience Portfolio Help to Diversify Its Business?

Zacks

22 days ago

Can BMYs Neuroscience Portfolio Help to Diversify Its Business?

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term

Zacks

22 days ago

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term

Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings

Zacks

22 days ago

Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings

Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

23 days ago

Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note

Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?

Simply Wall St.

23 days ago

Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?

Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years.

Barrons.com

24 days ago

Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years.

Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks

Insider Monkey

24 days ago

Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks

How Investors Are Reacting To Veeva Systems (VEEV) Winning Bristol Myers Squibb as a Vault CRM Client

Simply Wall St.

a month ago

How Investors Are Reacting To Veeva Systems (VEEV) Winning Bristol Myers Squibb as a Vault CRM Client

Hon Hai Technology Group (Foxconn) Chief Procurement Officer Honored In Alcott Global's Top 30 Supply Chain Leaders of 2025

PR Newswire

a month ago

Hon Hai Technology Group (Foxconn) Chief Procurement Officer Honored In Alcott Global's Top 30 Supply Chain Leaders of 2025

Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery

Insider Monkey

a month ago

Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery

Bristol-Myers Squibb (BMY) Is Up 7.4% After FDA Fast Track Win for Alzheimer’s Drug Candidate

Simply Wall St.

a month ago

Bristol-Myers Squibb (BMY) Is Up 7.4% After FDA Fast Track Win for Alzheimer’s Drug Candidate

Can Novo Nordisk's Restructuring Program Drive its Return to Growth?

Zacks

a month ago

Can Novo Nordisk's Restructuring Program Drive its Return to Growth?

Bristol Myers Alzheimer's Drug Earns FDA Fast Track

GuruFocus.com

a month ago

Bristol Myers Alzheimer's Drug Earns FDA Fast Track

Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug?

Zacks

a month ago

Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug?

MT Newswires

a month ago

Kinaxis to Deploy Maestro Platform for Sweden's Sobi to Boost Rare Disease Supply Chains

Chinese healthcare, biotech firms flock to Hong Kong for IPOs

South China Morning Post

a month ago

Chinese healthcare, biotech firms flock to Hong Kong for IPOs

Bristol-Myers Squibb (BMY) Reports Strong Multiple Myeloma Data

Insider Monkey

a month ago

Bristol-Myers Squibb (BMY) Reports Strong Multiple Myeloma Data

Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Directly to Cash-Paying U.S. Customers

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Directly to Cash-Paying U.S. Customers

Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease

Business Wire

a month ago

Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.

Barrons.com

a month ago

Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires

a month ago

Sector Update: Health Care

MT Newswires

a month ago

Bristol-Myers Receives FDA Fast Track Designation for Early Alzheimer's Drug

MT Newswires

a month ago

Bristol-Myers Squibb, Takeda Join Apheris' OpenFold3 Drug Discovery AI Model

Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease

Business Wire

a month ago

Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease

Bristol Myers, Takeda to pool data for AI-based drug discovery

Reuters

a month ago

Bristol Myers, Takeda to pool data for AI-based drug discovery

What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices

Investor's Business Daily

a month ago

What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices

Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know

Zacks

a month ago

Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know

Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities

How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets

Insider Monkey

a month ago

How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets

AbbVie to launch ovarian cancer drug in UK at US price

Reuters

a month ago

AbbVie to launch ovarian cancer drug in UK at US price

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

A Fresh Look at Bristol Myers Squibb’s Valuation Following Its Patient Connect Expansion and Drug Discount Initiative

Simply Wall St.

a month ago

A Fresh Look at Bristol Myers Squibb’s Valuation Following Its Patient Connect Expansion and Drug Discount Initiative

Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios

Insider Monkey

a month ago

Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios

AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices

The Wall Street Journal

a month ago

AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices

MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?

Zacks

a month ago

MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?

Share on Social Networks: